KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gsk (GSK) Times Interest Earned (2016 - 2025)

Historic Times Interest Earned for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to -$15.53.

  • Gsk's Times Interest Earned fell 118158.92% to -$15.53 in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.49, marking a year-over-year decrease of 4503.37%. This contributed to the annual value of $6.01 for FY2024, which is 2942.5% down from last year.
  • Latest data reveals that Gsk reported Times Interest Earned of -$15.53 as of Q3 2025, which was down 118158.92% from -$10.99 recorded in Q2 2025.
  • Over the past 5 years, Gsk's Times Interest Earned peaked at -$1.21 during Q3 2024, and registered a low of -$15.53 during Q3 2025.
  • For the 5-year period, Gsk's Times Interest Earned averaged around -$7.96, with its median value being -$7.08 (2021).
  • Per our database at Business Quant, Gsk's Times Interest Earned skyrocketed by 9196.37% in 2021 and then tumbled by 118158.92% in 2025.
  • Over the past 5 years, Gsk's Times Interest Earned (Quarter) stood at -$2.62 in 2021, then crashed by 46.67% to -$3.84 in 2022, then plummeted by 38.91% to -$5.33 in 2023, then rose by 12.09% to -$4.69 in 2024, then plummeted by 231.23% to -$15.53 in 2025.
  • Its Times Interest Earned stands at -$15.53 for Q3 2025, versus -$10.99 for Q2 2025 and -$13.68 for Q1 2025.